Study of somatrogon for pediatric growth hormone deficiency in India
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how well somatrogon works for children 3 years and older with growth hormone deficiency. It may help you understand if this treatment is an option for your child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 3 years old or older with pediatric growth hormone deficiency.
- Your child must be prescribed somatrogon by their doctor.
- You or your child must sign a consent form agreeing to take part.
- Your child must not be in any other clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This trial is looking at how well Sogroya® (a growth hormone medicine) works when used for a long time in children with short stature caused by growth hormone deficiency. The goal is to see if it helps them grow taller safely.
This study tests a new growth hormone treatment called GenSci134 for children who have not yet gone through puberty and are not growing because their bodies do not make enough growth hormone. The goal is to see if the medicine helps them grow taller.
This trial tests if a new weekly growth hormone shot (somatrogon) works as well as a daily one (Genotropin) for children who are short because they were born small or have no clear cause.
This study tracks the safety of lonapegsomatropin in children being treated for growth hormone deficiency (GHD). It’s meant to check for side effects and make sure the medicine continues to be safe in real-world use.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
Hear when a new Dwarfism, Pituitary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.